Concepts (130)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- Academic Medical Centers
- Adenine
- Adolescent
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Anemia
- Animals
- Antigens, CD19
- Anti-Inflammatory Agents
- Antineoplastic Agents
- Antineoplastic Agents, Phytogenic
- Antineoplastic Combined Chemotherapy Protocols
- Antiviral Agents
- Apoptosis
- Apoptosis Regulatory Proteins
- bcl-X Protein
- B-Lymphocytes
- Boston
- Breast Neoplasms
- Camptothecin
- Cardiology Service, Hospital
- Cell Cycle
- Cell Differentiation
- Cell Line
- Cell Line, Tumor
- Central Nervous System
- Chimerism
- Clinical Trials, Phase III as Topic
- Cohort Studies
- Coronavirus Infections
- Cyclophosphamide
- Cytotoxicity, Immunologic
- Disease Management
- Disease Models, Animal
- DNA Damage
- DNA, Neoplasm
- Drug Resistance, Neoplasm
- Female
- Flow Cytometry
- Gene Order
- Genes, cdc
- Genes, erbB-2
- Genes, p53
- Genetic Vectors
- Germinal Center
- Graft vs Host Disease
- Health Services Accessibility
- Health Status Disparities
- Healthcare Disparities
- Heart Failure
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cells
- Humans
- H-Y Antigen
- Immunization, Passive
- Immunomodulation
- Immunotherapy
- Immunotherapy, Adoptive
- Inpatients
- Isoantibodies
- Killer Cells, Natural
- Lentivirus
- Leukemia, Lymphocytic, Chronic, B-Cell
| - Leukocytes, Mononuclear
- Lymph Nodes
- Lymphocyte Activation
- Lymphocyte Depletion
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Male
- Maximum Tolerated Dose
- Mice
- Mice, Inbred NOD
- Mice, SCID
- Mice, Transgenic
- Middle Aged
- Molecular Targeted Therapy
- Multicenter Studies as Topic
- Mutation
- Myeloid Cells
- Neoplasm Proteins
- Neoplasm, Residual
- Neoplasms
- Neurotoxicity Syndromes
- Opportunistic Infections
- Pandemics
- Patient Admission
- Patient Readmission
- Piperidines
- Pneumocystis carinii
- Pneumonia, Pneumocystis
- Pneumonia, Viral
- Prognosis
- Prospective Studies
- Protein Kinase Inhibitors
- Protein Kinases
- Proteomics
- Proto-Oncogene Proteins c-bcl-2
- Pyrazoles
- Pyrimidines
- Randomized Controlled Trials as Topic
- Receptors, Antigen
- Receptors, Antigen, T-Cell
- Receptors, Estrogen
- Receptors, Progesterone
- Recurrence
- Retreatment
- Retrospective Studies
- Ribosomal Protein S6
- Risk Assessment
- Risk Factors
- RNA, Messenger
- Staurosporine
- Survival Analysis
- Th2 Cells
- Thiophenes
- Time Factors
- Tissue Donors
- T-Lymphocytes
- Transduction, Genetic
- Transplantation, Homologous
- Treatment Outcome
- Tumor Suppressor Protein p53
- Urea
- Withholding Treatment
- Xenograft Model Antitumor Assays
- Young Adult
|
Concepts
(130)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(80)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_